Consumer medicine information

Sporanox Capsules

Itraconazole

BRAND INFORMATION

Brand name

Sporanox Capsules

Active ingredient

Itraconazole

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Sporanox Capsules.

What is in this leaflet

This leaflet answers some common questions about SPORANOX capsules. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking SPORANOX capsules against the benefits this medicine is expected to have for you.

If you have any concerns about taking SPORANOX capsules, ask your doctor or pharmacist.

Keep this leaflet with your medicine. You may need to read it again.

What SPORANOX capsules are used for

SPORANOX capsules are used to treat certain fungal infections which include the following:

  • persistent infections of the nails, skin, hands, feet or groin;
  • persistent candida (yeast) infections of the vagina;
  • eye infections which have not responded to other treatment or which may be affecting vision;
  • candida (yeast) infections of the mouth or throat in patients with lower resistance to disease;
  • generalised infections.

SPORANOX works by killing or stopping the growth of the fungus that causes the infection.

Your doctor may have prescribed SPORANOX capsules for another reason. Ask your doctor if you have any questions about why this medicine has been prescribed for you.

Before you take SPORANOX capsules

When you must not take it

Do not take SPORANOX capsules if:

  • you are pregnant or may become pregnant.
    If there is any chance of you becoming pregnant, talk to your doctor about the need for highly effective contraception. Once you have finished taking SPORANOX, you should continue using highly effective contraception until you have had your next period. Tell your doctor immediately if you do become pregnant while taking SPORANOX.
  • you have a condition called heart failure (also called congestive heart failure or CHF), SPORANOX could make it worse. If your doctor decides that you need to take SPORANOX even if you have this condition, be sure to get immediate medical help if you have shortness of breath, unexpected weight gain, swelling of the legs, unusual fatigue, or begin to wake up at night.
  • you have an allergy to SPORANOX capsules or any of the ingredients. See Product Description at the end of this leaflet.

SPORANOX capsules must not be taken with certain medicines. Please refer to the section 'Before you start to take it, Taking other medicines.' for a list of these medicines. Do not take SPORANOX capsules if the packaging is torn or shows signs of tampering.

Do not take SPORANOX capsules beyond the expiry date (month and year) printed on the pack.

Before you start to take it

You must tell your doctor if:

  • you are breast feeding or wish to breastfeed;
  • you have had an allergic reaction to other medicines used to treat fungal infections;
  • you have or have had any liver problems;
  • you have or have had any kidney problems;
  • you have heart problems
  • you are a neutropenic, AIDS or an organ transplant patient.
  • you are a cystic fibrosis patient.

If you have not told your doctor or pharmacist about any of the above, tell them before you start taking or are given SPORANOX capsules.

Your doctor will advise whether or not to take SPORANOX or if you need to adjust the dose or adapt your treatment.

Taking other medicines

Tell your doctor or pharmacist if you are taking any other medicines, including medicines you can buy without a prescription from a pharmacy, supermarket or health food shop.

In particular, SPORANOX capsules must not be taken with the following medicines.

  • terfenadine, astemizole or mizolastine (used for allergy or hayfever);
  • bepridil, felodipine, nisoldipine, lercanidipine, ivabradine, ranolazine, eplerenone (used to treat angina (crushing chest pain) or high blood pressure);
  • cisapride (used for certain digestive problems);
  • midazolam (oral) or triazolam (used to produce calmness or to help you sleep);
  • simvastatin, lomitapide or lovastatin (used to lower your cholesterol);
  • lurasidone, pimozide or sertindole (used to treat mental disorders);
  • disopyramide, dronedarone, quinidine or dofetilide (used to treat irregular heartbeats);
  • levacetylmethadol, methadone (used for severe pain and to manage opioid-dependency);
  • ticagrelor (used for the prevention of heart attack or stroke);
  • dihydroergotamine and ergotamine (used to treat migraine);
  • ergomatrine or methylergometrine (used to control bleeding and maintain uterine contraction after child birth);
  • halofantrine (used to treat malaria);
  • irinotecan, mobocertinib (used to treat cancer);
  • domperidone (used to treat nausea and vomiting);
  • isavuconazole (used to treat fungal infections);
  • naloxegol (used to treat constipation caused by taking opioid painkillers);
  • avanafil (used to treat erectile dysfunction);
  • dapoxetine (used to treat premature ejaculation);
  • eliglustat (if you know you do not break down drugs that are broken down by the enzyme known as CYP2D6, you should check with your doctor if you can take this medicine)
  • finerenone (used to treat kidney problems in patients with type 2 diabetes);
  • voclosporin (used to treat lupusrelated kidney problems).

Medicines that must never be taken while you are taking SPORANOX capsules, if you have kidney or liver problems:

  • colchicine (used to treat gout);
  • fesoterodine or solifenacin, when used to control irritated urinary bladder;
  • telithromycin (an antibiotic).

If you have chronic lymphocytic leukemia/small lymphocytic lymphoma and you want to newly start this medicine or are making dose adjustments:

  • venetoclax (used to treat certain cancers).

Wait at least 2 weeks after stopping SPORANOX capsules before taking any of these medicines.

Certain medicines are not recommended because they may be affected by SPORANOX capsules or may affect how well SPORANOX capsules work. Your doctor may need to adjust the dose or adapt your treatment for these medicines:

  • phenytoin, phenobarbital or carbamazepine (used to treat fits);
  • bedaquiline, delamanid, rifampicin, rifabutin or isoniazid (used to treat tuberculosis);
  • certain medicines used to treat HIV/AIDS, such as cobicistat, boosted elvitegravir, efavirenz, indinavir, maraviroc, nevirapine, saquinavir and ritonavir, boosted darunavir, ritonavir-boosted fosamprenavir, tenofovir disoproxil fumerate (TDF);
  • boosted asunaprevir, boceprevir, daclatasvir, vaniprevir (used to treat hepatitis C);
  • glecaprevir/pibrentasvir; elbasvir/grazoprevir; ombitasvir/paritaprevir/ritonavir (with or without dasabuvir) combinations, to treat Hepatitis C
  • certain antineoplastics such as axitinib, bosutinib, bortezomib, brentuximab vedotin, busulphan, carbazitaxel, cabozanitinib, ceritinib, cobimetinib, crizotinib, dabrafenib, dasatinib, docetaxel, entrectinib, erlotinib, gefitinib, glasdegib, ibrutinib, idelalisib, imatinib, ixabepilone, lapatinib, nilotinib, nintedanib, olaparib, panobinostat, pazopanib, pemigatinib, ponatinib, regorafenib, ruxolitinib, sunitinib, sonidegib, talazoparib, trabectedin, trastuzumab emtansine, tretinoin (oral), vandetanib, vinca alkaloids (used to treat certain cancers);
  • aliskiren, diltiazem (to treat hypertension);
  • bosentan, digoxin, nadolol, riociguat, and certain calcium channel blockers including dihydropyridines (e.g. amlodipine, nifedipine) and verapamil (used to treat heart or blood pressure problems);
  • vorapaxar (used to treat heart attacks or strokes);
  • atorvastatin (used to lower cholesterol);
  • anticoagulants such as apixaban, edoxaban, coumarins & coumarin-like medicines (e.g. warfarin), cilostazol, dabigatran, rivaroxaban (used to slow blood clotting);
  • alfuzosin, dutasteride, silodosin (used to treat Benign Prostatic enlargement);
  • sildenafil (used to treat erectile dysfunction or pulmonary hypertension);
  • tadalafil, udenafil, vardenafil (used to treat erectile dysfunction);
  • colchicine (used to treat gout);
  • conivaptan, tolvaptan (used to treat low blood sodium levels);
  • mozavaptan; to treat low blood sodium;
  • fentanyl, a strong medicine for pain;
  • alfentanil, buprenorphine, oxycodone, sufentanil (used in surgery for pain relief and to help anaesthesia);
  • meloxicam, to treat joint inflammation and pain;
  • salmeterol (to improve breathing)
  • darifenacin, fesoterodine, imidafenacin, oxybutynin, tolterodine (used to treat urinary incontinence);
  • tamsulosin (used to treat male urinary incontinence)
  • ciprofloxacin, clarithromycin, erythromycin, telithromycin (antibiotics);
  • methylprednisolone, budesonide, ciclesonide, fluticasone and dexamethasone (often used for conditions such as inflammations, asthma and allergies);
  • bilastine, ebastine, rupatadine (used to treat allergies);
  • everolimus (given after an organ transplant)
  • cyclosporin, rapamycin (also known as sirolimus), tacrolimus, temsirolimus (used to help prevent organ transplant rejection or to treat certain problems with the immune system);
  • trimetrexate (used to treat certain type of pneumonia);
  • buspirone, perospirone, ramelteon, midazolam IV, alprazolam, brotizolam (used to treat anxiety or help you sleep);
  • aripiprazole, cariprazine, haloperidol, quetiapine, risperidone; to treat psychosis;
  • medicines taken for diabetes (in particular repaglinide and saxagliptin);
  • aprepitant, netupitant (used for nausea and vomiting during cancer treatment)
  • praziquantel, (used to treat fluke and tapeworms);
  • some contraceptive pills (birth control pills), such as dienogest, ulipristal;
  • reboxetine, venlafaxine (used to treat depression and anxiety);
  • cinacalcet, to treat an over active parathyroid;
  • alitretinoin (oral formulation), to treat eczema;
  • eletriptan (used to treat migraine);
  • medicines which neutralize stomach acid or suppress the production of stomach acid (such as antacids, cimetidine, ranitidine, omeprazole);
  • Saccharomyces boulardii, loperamide (used to treat diarrhea);
  • lumacaftor/ ivacaftor (used to treat Cystic Fibrosis);
  • guanfacine (used to treat Attention Deficit Hyperactivity Disorder);
  • suvorexant, zopiclone (used to treat insomnia);
  • cabergoline (used to treat Parkinsons Disease;
  • cannabinoids (used to treat nausea and vomiting, weight loss for patients with immune system problems and muscle spasms in patients with Multiple Sclerosis);
  • Valbenazine (used to treat movements of the mouth, tongue, jaw, and sometimes limbs, which cannot be controlled (tardive dyskinesia));
  • artemether-lumefantrine, quinine (used to treat malaria);
  • galantamine (used to treat Alzheimer's disease)

If you know you break down drugs that are handled/broken down by the enzyme CYP2D6 very quickly, you should check with your doctor if you can take this medicine as it may require a dose change:

  • eliglustat

Medicines not recommended while you are on SPORANOX capsules, when you are on a stable dose of this medicine for chronic lymphocytic leukemia/small lymphocytic lymphoma, or at any time of treatment for acute myeloid leukemia:

  • venetoclax

This is not a complete list of medicines. Therefore, tell your doctor about all medicines you take. Wait at least 2 weeks after stopping SPORANOX capsules before starting this medicine unless your doctor feels it is necessary.

Taking SPORANOX capsules

How much to take

Adults
The usual doses are shown below, but your doctor may decide to adjust them for your individual needs.

Tinea of body & groin:
1 capsule (100 mg) daily for 2 weeks.

Tinea of hands & feet:
1 capsule (100 mg) daily for 4 weeks.

Other skin infections:
2 capsules (200 mg) daily for 1 week.

Eye infections:
2 capsules (200 mg) daily for 3 weeks.

Vaginal infections:
2 capsules (200 mg) morning & evening for 1 day, or 2 capsules (200 mg) daily for 3 days.

Mouth infections:
1 to 2 capsules (100 mg to 200 mg) daily for 4 weeks.

Systemic infections:
1 to 2 capsules (100 mg to 200 mg) once or twice daily for 3 weeks to 8 months, depending on the condition.

Nail infections:

Continuous nail therapy

2 capsules (200 mg) once daily for 3 months.

Cyclic (pulse) nail therapy

2 capsules twice daily for 1 week. After that, stop taking SPORANOX for 3 weeks. Then the cycle is repeated, once for fingernails and twice for toenail infections (with or without fingernail infections). (See below).

Fingernails only
Week 1: Take 2 capsules twice daily.
Week 2, 3, 4: No SPORANOX.
Week 5: Take 2 capsules twice daily.
Week 6: Stop.
Toenails with or without fingernails
Week 1: Take 2 capsules twice daily.
Week 2, 3, 4: No SPORANOX.
Week 5: Take 2 capsules twice daily.
Week 6, 7, 8: No SPORANOX.
Week 9: Take 2 capsules twice daily.
Week 10: Stop.

Children and Elderly

SPORANOX capsules are not recommended for use in children and in the elderly.

How to take it

  • Always take SPORANOX capsules after a meal. The capsules must be swallowed whole.
  • Do not take medicines that neutralise stomach acid within 2 hours of taking SPORANOX capsules. This is because sufficient stomach acid is required to ensure that SPORANOX capsule is properly absorbed by the body. If you take medicines that suppress the production of stomach acid, you should take your SPORANOX capsules with an acidic drink, such as a cola beverage.

If you forget to take it

  • Take the dose you missed as soon as you remember, and then continue to take it as you would normally.
  • If it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to.
  • Do not take a double dose to make up for the one you missed.

If you have missed more than one dose, or are not sure what to do, check with your doctor or pharmacist.

If you have trouble remembering when to take your medicine, ask your pharmacist for some hints.

If you have taken too much (overdose)

Immediately telephone your doctor or the Poisons Information Centre for advice, or go to Accident and Emergency at your nearest hospital.

Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.

Poisons Information Centre telephone numbers:

  • Australia: 13 11 26
  • New Zealand: 0800 POISON or 0800 764 766

Keep these telephone numbers handy.

While you are taking SPORANOX capsules

Things you must do

  • Always follow your doctor's instructions carefully.
  • If you have to take SPORANOX capsules continuously for more than 1 month, your doctor may ask you to have your blood checked regularly. This is to make sure that your liver is not affected.
  • If there is any chance of you becoming pregnant, talk to your doctor about the need for highly effective contraception. Once you have finished taking SPORANOX, you should continue using highly effective contraception until you have had your next period. Tell your doctor immediately if you do become pregnant while taking SPORANOX.
  • If you are about to start taking a new medicine, tell your doctor and pharmacist that you are taking SPORANOX capsules.
  • Always complete the treatment as directed by your doctor, even if the signs of infection have gone.

Things you must not do

  • Do not take SPORANOX capsules to treat any other complaint unless your doctor says so.
  • Do not give this medicine to anyone else, even if his or her symptoms seem similar to yours.

Things to be careful of

Be careful driving or operating machinery. You may feel dizzy while taking SPORANOX capsules. If you experience this or similar effects, you should avoid driving and using machines.

Make sure you know how you react to SPORANOX capsules before you drive a car, operate machinery or do anything else that could be dangerous if you are dizzy or lightheaded.

Side Effects

All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some side effects. Do not be alarmed by this list of possible side effects. You may not experience any of them.

Ask your doctor or pharmacist to answer any questions you may have.

Tell your doctor if you experience any of the following:

  • upset stomach, stomach pain or discomfort, bloating, nausea, vomiting, diarrhoea, constipation, an unpleasant taste in your mouth.
  • shortness of breath, headache, dizziness, fever.
  • confusion
  • cough, chills, cold or flu-like symptoms
  • inflammation of sinus or nose
  • a change in menstrual pattern.
  • unusual hair loss or thinning.
  • erectile dysfunction.
  • muscle weakness or pain, painful joints, tremors.
  • high or low blood pressure
  • sleepiness
  • excessive sweating

Tell your doctor immediately if you notice any of the following as you may need urgent medical care:

  • tingling, numbness or weakness in the hands or feet.
  • increased heart rate
  • chest pain
  • swelling of hands ankles, feet, legs or abdomen.
  • shortness of breath, unexpected weight gain, unusual fatigue, or begin to wake up at night (heart failure).
  • oversensitivity to sunlight.
  • blurry or double vision, ringing in the ears.
  • lose the ability to control your bladder or urinate much more than usual.

STOP taking SPORANOX capsules and tell your doctor immediately or go to Accident and Emergency at your nearest hospital if any of the following happen:

  • abnormal tiredness, loss of appetite, nausea, vomiting, abdominal pain, dark urine, pale stools, yellowing of the skin or eyes (liver disorder).
  • sudden signs of allergy such as rash, itching or hives on the skin, swelling of the face, lips, tongue or other parts of the body, shortness of breath or difficulty breathing, wheezing or trouble breathing.
  • a severe skin disorder (widespread rashes with peeling skin and blisters in the mouth, eyes and genitals, or rashes with small pustules or blisters).
  • you experience any hearing loss symptoms. In very rare cases, patients taking SPORANOX have reported temporary or permanent hearing loss.

Other side effects not listed above may also occur in some people. Tell your doctor if you notice any other effects.

After using SPORANOX capsules

Storage

  • Keep SPORANOX capsules in the pack until it is time to take them.
  • Keep SPORANOX capsules in a cool dry place where the temperature is below 25°C.
  • Keep your medicines where young children cannot reach them. A locked cupboard at least one-and-a-half metres (1.5 m) above the ground is good place to store medicines.
  • Do not store SPORANOX capsules, or any other medicine, in the bathroom or near a sink. Do not leave medicines in the car or on window sills. Heat and dampness can destroy some medicines.

Disposal

If your doctor tells you to stop taking SPORANOX capsules or your medicines has passed its expiry date, ask your pharmacist what to do with any medicine which may be left over.

Product Description

What it looks like

SPORANOX capsules are pink and blue. They are supplied in a blister pack, containing:

  • 15, 28 or 60 capsules

Ingredients

The active ingredient in each SPORANOX capsule is 100 milligrams of itraconazole. Other ingredients include non-pareil beads, macrogol, and hypromellose. The capsule is made of gelatin and also contains titanium dioxide, indigo carmine and erythrosine.

SPORANOX capsules contains sugars.

SPORANOX capsules do not contain lactose or gluten.

Sponsor

Janssen-Cilag Pty Ltd
1-5 Khartoum Road
Macquarie Park NSW 2113 Australia
Telephone: 1800 226 334

NZ Office: Auckland New Zealand
Telephone: (09) 523 8700 or 0800 800 806

Australian Registration Number: AUST R 47012

This leaflet was prepared in July 2023

Published by MIMS September 2023

BRAND INFORMATION

Brand name

Sporanox Capsules

Active ingredient

Itraconazole

Schedule

S4

 

1 Name of Medicine

Itraconazole.

2 Qualitative and Quantitative Composition

Each capsule contains 100 mg of itraconazole.
Excipients with known effect. Sucrose.
For a full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Capsule.
Blue opaque cap and pink transparent body containing beads.

4 Clinical Particulars

4.9 Overdose

Symptoms. In general, adverse effects reported with overdose have been consistent with those reported for itraconazole use (see Section 4.8 Adverse Effects (Undesirable Effects)).
Treatment. Itraconazole is not removed by dialysis. In the event of accidental overdosage, supportive measures should be employed.
For information on the management of overdose, contact the Poisons Information Centre on 131126 (Australia).

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. Itraconazole produced no mutagenic effects when assayed in appropriate bacterial, nonmammalian and mammalian test systems.
Carcinogenicity. Itraconazole showed no evidence of carcinogenicity potential in mice treated orally for 23 months at dosage levels of up to 80 mg/kg/day. Male rats treated with 25 mg/kg/day had a slightly increased incidence of soft tissue sarcoma. These sarcomas may have been a consequence of hypercholesterolaemia, which is a response of rats, but not dogs or humans to chronic itraconazole administration.
Female rats treated with 50 mg/kg/day had an increased incidence of squamous cell carcinoma of the lung (2/50) as compared to the untreated group. Although the occurrence of squamous cell carcinoma in the lung is extremely uncommon in untreated rats, the increase in this study was not statistically significant.
Toxicology. In three toxicology studies using rats, itraconazole induced bone defects at dosage levels as low as 20 mg/kg/day. The induced defects included reduced bone plate activity, thinning of the zona compacta of the large bones and increased bone fragility. At a dosage level of 80 mg/kg/day over one year or 160 mg/kg/day for six months, itraconazole induced small tooth pulp with hypocellular appearance in some rats.
Increased relative adrenal weights and swollen adrenals (reversible) were seen in rats and dogs where plasma levels were comparable to those of human therapeutic doses. Adrenocortical function was not affected in studies in humans after the recommended daily doses; with higher doses (600 mg/day for 3 months), adrenal cortex response to ACTH stimulation was reduced in 1 of 8 patients, but returned to normal when the dosage was reduced.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

Itraconazole is a synthetic triazole antifungal agent. It has three chiral centres and is a 1:1:1:1 racemic mixture of four diastereomers (two enantiomeric pairs).
Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSITRACO.gif CAS number. 84625-61-6.

7 Medicine Schedule (Poisons Standard)

S4 - Prescription Only Medicine.

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/SPOCAPST.gif